May 6, 2011 – Results from an analysis of the ALTITUDE Clinical Science program demonstrated that defibrillator therapy saves lives from lethal arrhythmias without an increase in mortality due to defibrillator shock. Instead, the authors found that increased mortality risk associated with these shocks is not attributed to the defibrillator shock itself, but rather to the underlying medical condition leading to atrial and ventricular arrhythmias.

May 6, 2011 – Rhythmia Medical Inc. and Endosense have engaged in a joint development project to integrate the contact-force data provided by Endosense’s TactiCath force-sensing ablation catheter into Rhythmia’s advanced three-dimensional cardiac mapping, visualization and navigation system.

May 6, 2011 – The U.S. Food and Drug Administration has released its list of pre-market approval (PMA) decisions for new or enhanced medical devices from March 2011.

May 6, 2011 – The report recommends training focused on three levels of competency based on the individual interventional cardiologist's level of experience with simple and complex cases, including patients with challenging anatomy.


In a move that will likely have a significant impact how many patients are treated for carotid artery disease, the U.S. Food and Drug Administration (FDA) has cleared the use of a stent to treat standard-risk surgical patients. Prior to the approval, carotid stenting was only indicated for used in high-risk surgical patients who were often denied the standard-of-care of carotid endarterectomy surgery.

May 6, 2011 – Functionality in the echo ultrasound market drives satisfaction as providers push the bounds of what the technology can do to treat an increasing number of patients at risk for cardiovascular disease. Vendors have responded to these demands with new systems and new technology over the last couple of years.

May 5, 2011 – Volcano Corp. announced a supply agreement with ev3, a Covidien company, under which Volcano will supply its intravascular ultrasound (IVUS) technology for use in ev3's Plaque Excision Systems. Utilizing the digital IVUS transducer incorporated in Volcano's EagleEye catheter product line, this new product will be capable of running on Volcano's global installed base of 5,000 systems.

May 5, 2011 – A new warranty program is available in the United States that covers Boston Scientific’s cardiac resynchronization defibrillator (CRT-D) devices and leads in the event of chronic phrenic nerve stimulation (PNS).

May 5, 2011 – GE Healthcare is showing a complete portfolio of integrated electrophysiology (EP) products featuring electrical signals recording and anatomical imaging at the lowest dose, 3-D rotational angiography capabilities, and components integration.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now